Kevin Chan, OD, MS, FAAO, FBCLA, IACMM, stated in his Rapid Fire lecture that high myopes shouldn't be counted out of orthokeratology treatment.
|Articles|October 13, 2020
CooperVision releases MiSight 6-year data
6-year data on MiSight contact lenses
Advertisement
Paul Chamberlain, who serves as CooperVision’s director of research programs, myopia, spoke with Optometry Times® Editor in Chief Gretchyn Bailey about the company’s 6-year data on MiSight contact lenses. Chamberlain discussed clinical implications of the data and next steps for following children wearing the daily disposable myopia management contact lenses.
Advertisement
Related to this article
Magdalena Stec, OD, FAAO, and Noreen Shaikh, OD, MEd, FAAO, gave an overview of current evidence-based myopia control treatments in part of their AAOpt 2026 session.
Host Hamza Shah, OD, MS, FAAO, is joined by Cory Lappin, OD, MS, FAAO, to discuss dynamic muscle stimulation for dry eye, spurred by a paper on improving blinking in dry eye patients.
Dry eye questionnaires capture only 22.4% of Demodex blepharitis symptoms, and a 22-study review links Demodex infestation to worse meibomian gland function.
Shane Kannarr, OD, overviews results from a phase 4, multicenter, prospective, open-label trial that evaluated the impact of concomitant use of PFHO during contact lens wear.
Real-world PFHO data show OSDI scores falling within 2 weeks, while a 12-month trial finds stable corneal endothelial cell density with cyclosporine 0.1%.
David Webley, BSc (Hons), MCOptom, FBCLA, weighs in on SightGlass Vision's latest data presented at AAOpt's annual meeting in Anaheim, California.
Aldeyra Therapeutics will submit a FDRR to the FDA for reproxalap, an investigational drug or dry eye disease.
Advertisement
Advertisement
Trending on Optometry Times - Clinical News & Expert Optometrist Insights
1
What is the biggest barrier to eye care access worldwide?
2
AAOpt 2026: Optimizing the ocular surface for cataract/refractive surgery: A case study
3
AAOpt 2026: Photobiomodulation to revolutionize dry AMD treatment, Dr Rafieetary says
4
AAOpt 2026: Brimonidine-hyaluronic acid drop sustains redness relief through 10 hours
5